GHRP-6: A Hormone Signal Is Not an Outcome
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

GHRP-6 is a synthetic peptide that acts through the ghrelin-receptor system. That system connects signals about energy balance with growth-hormone release. Small human experiments have measured growth-hormone responses. Some also measured ACTH and cortisol, reminding us that changing a signaling pathway can affect more than one hormone. The appetite story needs its own evidence label. A study showing more food intake after GHRP-6 was conducted in rats. That does not quantify the response in people. A short-term hormone change does not establish better recovery, healthy aging, or lasting muscle benefit. FDA flags safety concerns, including glucose and cortisol effects.

END CARD
Research explained. Not medical advice. Sources and limitations in the accompanying transcript.

SOURCES
[1] GHRP-6 stimulates sleep, GH, ACTH and cortisol release in normal man (1995)
https://pubmed.ncbi.nlm.nih.gov/7617137/
Primary human endocrine study

[2] Glucocorticoid-dependent stimulation of adiposity and appetite by a ghrelin mimetic in the rat
https://pubmed.ncbi.nlm.nih.gov/15191362/
Primary animal experiment

[3] FDA peptide safety information: GHRP-6
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
US regulator

EVIDENCE LIMITATIONS
Do not substitute human ghrelin or GHRP-2 appetite studies for GHRP-6-specific evidence.
Acute endocrine studies do not establish long-term efficacy or safety.
Avoid a claim that GHRP-6 selectively changes only growth hormone.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
https://www.facebook.com/reel/2141557456757173/